Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: June 25, 2017
What are the generic drug sources for bupivacaine hydrochloride and what is the scope of bupivacaine hydrochloride freedom to operate?
Bupivacaine hydrochloride is the generic ingredient in twelve branded drugs marketed by Fresenius Kabi Usa, Sagent Agila, Hospira, Intl Medicated, Claris, Aurobindo Pharma Ltd, Septodont, and Amphastar Pharms Inc, and is included in thirty-seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.| Tradenames: | 12 |
| Patents: | 1 |
| Applicants: | 8 |
| NDAs: | 37 |
| Drug Master File Entries: see list | 10 |
| Suppliers / Packagers: see list | 13 |
| Bulk Api Vendors: see list | 62 |
| Clinical Trials: see list | 2,854 |
| Patent Applications: see list | 718 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | bupivacaine hydrochloride at DailyMed |
| Ingredient-type | Amides Catecholamines |
| Drug Class | Amide Local Anesthetic alpha-Adrenergic Agonist beta-Adrenergic Agonist Catecholamine |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
| Physiological Effect | Local Anesthesia |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | bupivacaine hydrochloride; epinephrine | INJECTABLE;INJECTION | 071169-001 | Jun 16, 1988 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Fresenius Kabi Usa | SENSORCAINE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 070553-001 | May 21, 1986 | AP | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Aurobindo Pharma Ltd | BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 203895-002 | Nov 5, 2013 | AP | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Hospira | MARCAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 016964-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ► Subscribe | ► Subscribe | ||||||||||||||||||
Claris | BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;SPINAL | 207266-001 | Jul 25, 2016 | AP | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
Join the 21,684 other biopharmaceutical professionals who get our Drug Patent Expiration Alerts:
